Abstract:Background: As cancer metastasis is the deadliest aspect of cancer, causing 90% of human deaths, evaluating the molecular mechanisms underlying this process is the major interest to those in the drug development field. Both therapeutic target identification and proof-of-concept experimentation in anti-cancer drug development require appropriate animal models, such as xenograft tumor transplantation in transgenic and knockout mice. In the progression of cancer metastasis, circulating tumor cells (CTCs) are the most critical factor in determining the prognosis of cancer patients. Several studies have demonstrated that measuring CTC-specific markers in a clinical setting (e.g., flow cytometry) can provide a current status of cancer development in patients. However, this useful technique has rarely been applied in the real-time monitoring of CTCs in preclinical animal models. Methods: In this study, we designed a rapid and reliable detection method by combining a bioluminescent in vivo imaging system (IVIS) and quantitative polymerase chain reaction (QPCR)-based analysis to measure CTCs in animal blood. Using the IVIS Spectrum CT System with 3D-imaging on orthotropic-developed breast-tumor-bearing mice. Results: In this manuscript, we established a quick and reliable method for measuring CTCs in a preclinical animal mode. The key to this technique is the use of specific human and mouse GUS primers on DNA/RNA of mouse peripheral blood under an absolute qPCR system. First, the high sensitivity of cancer cell detection on IVIS was presented by measuring the luciferase carried MDA-MB-231 cells from 5 to 5x1011 cell numbers with great correlation (R2 = 0.999). Next, the MDA-MB-231 cell numbers injected by tail vein and their IVIS radiance signals were strongly corrected with qPCR-calculated copy numbers (R2 > 0.99). Furthermore, by applying an orthotropic implantation animal model, we successfully distinguished xenograft tumor-bearing mice and control mice with a significant difference (p < 0.001), whereas IVIS Spectrum-CT 3D-visualization showed that blood of mice with lung metastasis contained more than twice the CTC numbers than ordinary tumor-bearing mice. We demonstrated a positive correlation between lung metastasis status and CTC numbers in peripheral mouse blood. Conclusion: Collectively, the techniques developed for this study resulted in the integration of CTC assessments into preclinical models both in vivo and ex vivo, which will facilitate translational targeted therapy in clinical practice.

Monitoring circulating tumor cells in vivo by a confocal microscopy system

Isolation and characterization of living circulating tumor cells in patients by immunomagnetic negative enrichment coupled with flow cytometry.

A Noninvasive and Real-Time Method for Circulating Tumor Cell Detection by In Vivo Flow Cytometry.

Real Time Monitoring of Daily Variation of Circulating Tumor Cells by in Vivo Flow Cytometry (conference Presentation)

Circulating tumor cells occur nonuniformly monitored by in vivo flow cytometry

Monitoring Circulating Tumor Cells by In-Vivo Flow Cytometry

Self-Sterilizing and Regeneratable Microchip for the Precise Capture and Recovery of Viable Circulating Tumor Cells from Patients with Cancer.

A rapid and quantitative method to detect human circulating tumor cells in a preclinical animal model

Real-Time Monitoring Of Rare Circulating Hepatocellular Carcinoma Cells In An Orthotopic Model By In Vivo Flow Cytometry Assesses Resection On Metastasis

In Vivo Flow Cytometry Visualizes the Effects of Tumor Resection on Metastasis by Real-Time Monitoring of Rare Circulating Cancer Cells

Advances of In Vivo Flow Cytometry on Cancer Studies

Noninvasive and real-time monitoring of Au nanoparticle promoted cancer metastasis using in vivo flow cytometry

Visualizing Interactions of Circulating Tumor Cell and Dendritic Cell in the Blood Circulation Using in Vivo Imaging Flow Cytometry

Comparison of Three Different Methods for the Detection of Circulating Tumor Cells in Mice with Lung Metastasis.

An innovative approach to detect circulating tumor cells

Progress in Detection of CirculatingTumor Cell byin vivo Photoacoustic Flow Cytometry

Data from Real-Time Monitoring of Rare Circulating Hepatocellular Carcinoma Cells in an Orthotopic Model by <i>In Vivo</i> Flow Cytometry Assesses Resection on Metastasis

Data from Real-Time Monitoring of Rare Circulating Hepatocellular Carcinoma Cells in an Orthotopic Model by <i>in Vivo</i> Flow Cytometry Assesses Resection on Metastasis

Circulating tumor cells: advances in detection methods, biological issues, and clinical relevance

In vivo flow cytometry: A powerful optical technology to detect circulating tumor cells and diagnose cancer metastasis in vivo/In-vivo-Durchflusszytometrie: Ein leistungsstarkes optisches Verfahren zur Detektion zirkulierender Tumorzellen und zur In-vivo-Diagnose von Metastasen

Advances in isolation and detection of circulating tumor cells based on microfluidics